Date Initiated by Firm | June 10, 2011 |
Date Posted | July 27, 2011 |
Recall Status1 |
Terminated 3 on April 04, 2012 |
Recall Number | Z-2881-2011 |
Recall Event ID |
59101 |
510(K)Number | K061718 |
Product Classification |
Enzyme Immunoassay, Amphetamine - Product Code DKZ
|
Product | Calloway LabsMulti-Drug 9 Panel Assay
A rapid, one step screening test for the simultaneous for the qualitative detection of multiple drugs and drug metabolites in human urine. |
Code Information |
Model/Catalog Number: DOA-197-201-19-0NW506A, Lot/Unit Codes: DOA1040725, DOA1040758, DOA1040784, DOA1040669 & DOA1040689 |
Recalling Firm/ Manufacturer |
Alere San Diego 9975 Summers Ridge Rd San Diego CA 92121-2997
|
For Additional Information Contact | 858-455-4808 Ext. 3015 |
Manufacturer Reason for Recall | Alere is initiating a voluntary recall on the listed lots of MULTI-DRUG 9 PANEL INTEGRATED CUP manufactured by Alere for sole use by Calloway Labs due to a mistake that occurred while processing the order, these products were incorrectly
labeled as CLIA Waived, when in fact the devices are classified as Moderately Complex. Therefore these devices are misbranded. |
FDA Determined Cause 2 | Vendor change control |
Action | Alere San Diego sent an "Urgent Medical Device Recall" letter dated June 9, 2011 to all affected customers.
The letter included: products affected, reason for recall and instructed them to return all affected product. An acknowledgement form was also included for the customer to return to Alere.
For questions contact Technical Services at 888.246.7483, option 2 or by e-mail at InnovaconComplaints@alere.com. |
Quantity in Commerce | 2400 kits (60,000 devices) |
Distribution | (USA) Nationwide Distribution including the states of MO and MA. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = DKZ
|